# DIAZOXIDE
> **ANDA211050** · Abbreviated New Drug Application (Generic) · Sponsor: E5 PHARMA INC · Approved 2019-12-20
## Drug
- **FDA Application Number:** ANDA211050
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DIAZOXIDE
- **Generic name:** DIAZOXIDE
- **Active ingredients:** DIAZOXIDE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** E5 PHARMA INC
- **Manufacturer:** e5 Pharma, LLC
- **First approval:** 2019-12-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211050)
---
*AI Analytics · CC0 1.0*